Related Experiment Video
Updated: Jul 30, 2025
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Deletions of DNA in cancer and their possible uses for therapy
Alexander Varshavsky1, Kim Lewis2, Shun-Jia Chen1
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Abstract:
Despite advances in treatments over the last decades, a uniformly reliable and free of side effects therapy of human cancers remains to be achieved. During chromosome replication, a premature halt of two converging DNA replication forks would cause incomplete replication and a cytotoxic chromosome nondisjunction during mitosis. In contrast to normal cells, most cancer cells bear numerous DNA deletions. A homozygous deletion permanently marks a cell and its descendants. Here, we propose an approach to cancer therapy in which a pair of sequence-specific roadblocks is placed solely at two cancer-confined deletion sites that are located ahead of two converging replication forks. We describe this method, termed "replication blocks specific for deletions" (RBSD), and another deletions-based approach as well. RBSD can be expanded by placing pairs of replication roadblocks on several different chromosomes. The resulting simultaneous nondisjunctions of these chromosomes in cancer cells would further increase the cancer-specific toxicity of RBSD.
Insights
This study introduces a novel cancer therapy strategy using targeted DNA replication blocks. This approach exploits cancer-specific deletions to induce chromosome nondisjunction, offering a potential new avenue for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer treatment faces challenges with side effects and uniform efficacy.
- Cancer cells often exhibit unique DNA deletions, unlike normal cells.
- Incomplete DNA replication due to halted replication forks can lead to cell death.
Purpose of the Study:
- To propose a novel cancer therapy targeting cancer-specific DNA deletions.
- To develop a method for inducing cancer-specific chromosome nondisjunction.
- To enhance the specificity and toxicity of cancer treatments.
Main Methods:
- Introducing sequence-specific replication roadblocks at cancer-confined deletion sites.
- Utilizing the "replication blocks specific for deletions" (RBSD) approach.
- Expanding RBSD by targeting multiple deletion sites across different chromosomes.
Main Results:
- The proposed RBSD method targets unique deletion sites in cancer cells.
- Placing roadblocks at converging replication forks causes premature halts.
- Simultaneous nondisjunction of multiple chromosomes can be induced in cancer cells.
Conclusions:
- RBSD offers a cancer-specific therapeutic strategy by exploiting DNA deletions.
- This approach leverages replication stress to induce cancer cell death.
- Targeting multiple deletions may significantly increase the efficacy and specificity of cancer therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:37Epigenetic Regulation
X-chromosome...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:59CRISPR
02:56Treatment Resistant Cancers